Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Huang, Ying ^a   Yang, Zhen ^b   Ye, Zi ^a   Li, Qin ^a   Wen, Jie ^a   Tao, Xiaoming ^a   Chen, Lili ^a   He, Min ^a   Wang, Xuanchun ^a   Lu, Bin ^a   Zhang, Zhaoyun ^a   Zhang, Weiwei ^c   Qu, Shen ^b   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Impaired glucose regulation; Insulin resistance; Lipocalin 2; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GLUCOSE; INSULIN; LIPID; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; AUTACOID; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHINESE; CHRONIC INFLAMMATION; CHRONIC LOW GRADE SYSTEMIC INFLAMMATION; CIGARETTE SMOKING; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; WAIST HIP RATIO; ASIAN; BLOOD; CHINA; CHRONIC DISEASE; ETHNOLOGY; GLUCOSE INTOLERANCE; INFLAMMATION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; RISK; RISK ASSESSMENT; STATISTICAL MODEL; UPREGULATION;

ACUTE-PHASE PROTEINS; ADIPOKINES; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHINA; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; LIPIDS; LIPOCALINS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 84856363510     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-11     Document Type: Article

References (32)

1. Gelsinger C, Tschoner A, Kaser S, Ebenbichler CF. Adipokine update - new molecules, new functions. Wien Med Wochenschr 2010, 160(15-16):377-390. 10.1007/s10354-010-0781-6, 20812049.
2. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008, 93(11 Suppl 1):S64-S73. 2585759, 18987272.
3. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003, 24(3):278-301. 10.1210/er.2002-0010, 12788800.
4. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268(14):10425-10432.
5. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994, 83(3):799-807.
6. Flower DR. The up-and-down beta-barrel proteins: three of a kind. FASEB J 1995, 9(7):566-567.
7. Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001, 293(5531):829-834. 10.1126/science.1061075, 11486081.
8. Stoesz SP, Gould MN. Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas. Oncogene 1995, 11(11):2233-2241.
9. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432(7019):917-921. 10.1038/nature03104, 15531878.
10. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, Houstis NE, Kahn BB, Rosen ED. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007, 56(10):2533-2540. 10.2337/db07-0007, 17639021.
11. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, Chow WS, Wat NM, Xu JY, Hoo RL, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007, 53(1):34-41.
12. Law IK, Xu A, Lam KS, Berger T, Mak TW, Vanhoutte PM, Liu JT, Sweeney G, Zhou M, Yang B, et al. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 2010, 59(4):872-882. 10.2337/db09-1541, 2844835, 20068130.
13. Auguet T, Quintero Y, Terra X, Martinez S, Lucas A, Pellitero S, Aguilar C, Hernandez M, Del CD, Richart C. Upregulation of Lipocalin 2 in Adipose Tissues of Severely Obese Women: Positive Relationship With Proinflammatory Cytokines. Obesity (Silver Spring) 2011, 19(12):2295-300.
14. Yang Z, Zhang Z, Wen J, Wang X, Lu B, Yang Z, Zhang W, Wang M, Feng X, Ling C, et al. Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people. J Clin Endocrinol Metab 2010, 95(8):3926-3932. 10.1210/jc.2009-2194, 20501684.
15. Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002, 15(1):83-96.
16. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28:S37-S42. American Diabetes Association.
17. Cakal E, Ozkaya M, Engin-Ustun Y, Ustun Y. Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome. J Endocrinol Invest 2011, 34(2):97-100.
18. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002, 10(5):1045-1056. 10.1016/S1097-2765(02)00710-4, 12453413.
19. Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 2004, 145(11):5305-5312. 10.1210/en.2004-0392, 15308612.
20. Borel MJ, Beard JL, Farrell PA. Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats. Am J Physiol 1993, 264(3 Pt 1):E380-E390.
21. Farrell PA, Beard JL, Druckenmiller M. Increased insulin sensitivity in iron-deficient rats. J Nutr 1988, 118(9):1104-1109.
22. Dandona P, Hussain MA, Varghese Z, Politis D, Flynn DM, Hoffbrand AV. Insulin resistance and iron overload. Ann Clin Biochem 1983, 20(Pt 2):77-79.
23. Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, Ye X, Qi Q, Wang J, Pan A, et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab 2008, 93(12):4690-4696. 10.1210/jc.2008-1159, 18796516.
24. Jin D, Guo H, Bu SY, Zhang Y, Hannaford J, Mashek DG, Chen X. Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure. FASEB J 2011, 25(2):754-764. 10.1096/fj.10-165175, 3023388, 20974668.
25. Jun LS, Siddall CP, Rosen ED. A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance. Am J Physiol Endocrinol Metab 2011, 301(5):E825-E835. 10.1152/ajpendo.00147.2011, 21771968.
26. Alvehus M, Buren J, Sjostrom M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) 2010, 18(5):879-883.
27. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 2008, 22(6):1416-1426. 10.1210/me.2007-0420, 2422824, 18292240.
28. Kratchmarova I, Kalume DE, Blagoev B, Scherer PE, Podtelejnikov AV, Molina H, Bickel PE, Andersen JS, Fernandez MM, Bunkenborg J, et al. A proteomic approach for identification of secreted proteins during the differentiation of 3 T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002, 1(3):213-222. 10.1074/mcp.M200006-MCP200, 12096121.
29. Teixeira-Lemos E, Nunes S, Teixeira F, Reis F. Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 2011, 10:12. 10.1186/1475-2840-10-12, 3041659, 21276212.
30. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006, 97(2A):3A-11A.
31. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 2006, 47(8 Suppl):C19-C31.
32. Chavey C, Lazennec G, Lagarrigue S, Clape C, Iankova I, Teyssier J, Annicotte JS, Schmidt J, Mataki C, Yamamoto H, et al. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab 2009, 9(4):339-349. 10.1016/j.cmet.2009.03.002, 2804846, 19356715.